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We have previously shown that protein kinase C activators modulate diferentiated thyroid function in vitro; 
however, how protein kinase C may be activated physiologically is unknown. The present studies were un- 
dertaken in order to determine whether TSH could activate protein kinase C in vitro. Following exposure 
of porcine thyroid cells to TSH, translocation of protein kinase C from the cytosol to its membrane-bound 
form was observed. Maximal translocation occurred at the lowest TSH concentration able to trigger this 
response (10 mu/ml) but persisted at higher concentrations (2G-100 mu/ml). Time-course studies revealed 
that translocation of protein kinase C was seen only after 40 min. TSH could also produce a similar translo- 
cation in human neutrophils (known to have TSH receptors). In thyroid cells pre-treated with TSH, modula- 
tion of phorbol-mediated protein kinase C translocation was noted. These results indicate that TSH causes 
the translocation of protein kinase C in porcine thyroid cells (and possibly other TSH receptor-containing 
cells) and therefore may regulate the action of protein kinase C on differentiated thyroid function. 
Protein kinase C; Thyrotropin; Phorbol ester; (Thyroid cell) 
1. INTRODUCTION 
A signal transduction system involving receptor- 
mediated phospholipid turnover, diacylglycerol ac- 
cumulation and activation of a Ca*+- and 
phospholipid-dependent enzyme, protein kinase C, 
plays a role in many cellular responses [ 1). Recent- 
ly, evidence which implies that protein kinase C 
may be involved in the regulation of differentiated 
thyroid function has emerged. Tumor-promoting 
phorbol esters which are known activators of pro- 
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tein kinase C [1,2] have been shown to modulate 
differentiated thyroid function in vitro [3-61. We 
have demonstrated that under identical conditions, 
the phorbol ester, 12-0-tetradecanoyl phorbol 
13-acetate (TPA) can cause the translocation of 
protein kinase C from the cytosol to its membrane- 
bound form in thyroid cell extracts [6]. However, 
how protein kinase C may be activated in the 
thyroid remains unknown. Thyroid hormone syn- 
thesis is normally stimulated by the pituitary hor- 
mone, thyrotropin (TSH) via a receptor-linked 
cyclic AMP-responsive system [7]. Recently, TSH 
has been shown to stimulate inositol 1,4,5-tris- 
phosphate (IP3) generation in human thyroid slices 
independently of adenylate cyclase stimulation [8]. 
The present studies were to determine whether 
TSH could activate protein kinase C in vitro as 
demonstrated by its subcellular redistribution in 
porcine thyroid cells. 
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2. MATERIALS AND METHODS 
2.1. Chemicals 
TPA, ATP, Hl histone type IIIS, 1,2-diolein, 
phosphatidylserine, collagenase (type IA), PMSF 
and Nonidet P40 were obtained from Sigma. 
[T-~~P]ATP (3000 Ci/mmol) was purchased from 
New England Nuclear. DEAE-cellulose (DE52) 
was from Whatman. Bovine TSH (Thytropar) was 
supplied by Armour Pharmaceuticals. 
2.2. Methods 
2.2.1. Isolation of porcine thyroid cells 
Porcine thyroid cells were isolated using a 
discontinuous trypsinization process that has been 
previously described [9]. Cells were incubated with 
TSH in serum-free medium for 40 min (unless 
otherwise stated) at 37°C prior to washing, 
resuspension and assessment of protein. kinase C 
activity. 
2.2.2. Protein kinase C extraction 
Protein kinase C was measured as described [6]. 
Briefly, cells were sonicated in 20 mM Tris-Cl, pH 
7.6, containing 2 mM EDTA, 2 mM PMSF, 
0.5 mM EGTA, 0.33 M sucrose, pH 7.6 (Tepes 
buffer), and centrifuged at 115000 x g for 1 h. The 
supernatant was used as the cytosolic fraction and 
the pellet was resuspended in Tepes buffer contain- 
ing 1% NP40. Protein determinations were ac- 
cording to Lowry et al. [lo]. 
2.2.3. DE52 chromatography 
A modification of the procedure of Kraft and 
Anderson [l l] was employed. DE52 was washed 
and then equilibrated in 20 mM Tris-HCI, pH 7.6, 
0.5 mM EGTA, 1 mM PMSF, 2 mM EDTA (buf- 
fer A). The DE52 was then poured into a small 
plastic column (6.5 x 0.7 cm) and washed with 
2 ml buffer A. Cytosol or particulate extract in 1% 
NP40 from 1 x lo8 cells was applied and 0.1 M 
NaCl in buffer A was used to elute protein from 
the column. Each collected fraction was im- 
mediately assayed for protein kinase C activity. 
2.2.4. Protein kinase C assay 
Protein kinase C was assayed by measuring the 
incorporation of 32P from [T-~~P]ATP into histone 
Hl . The standard assay mixture (250 ~1) contained 
20 mM Tris-HCl, pH 7.6, 5Opg histones, 100pM 
224 
ATP (-50 cpm/pmol), 75 mM Mg acetate, 50~1 
sample and 5 mM CaC12, 25 pg phosphatidylserine 
and 0.8 pg 1,2-diolein. In the negative control 
samples, the latter 3 reagents were omitted and 
0.5 mM EGTA was added. After incubation for 
10 min at 30°C 30% trichloroacetic acid was add- 
ed to stop the reaction. The protein precipitate was 
collected on a 0.45 pm membrane filter (Millipore) 
and the incorporation of 32P was measured by scin- 
tillation counting in a Beckman LS 6800. En- 
zymatic activity was expressed as pmol 32P 
incorporated into histone/min per mg protein. All 
assays were performed in quadruplicate. 
2.2.5. Protein kinase C activation in human 
neutrophils 
Isolated human neutrophils were incubated with 
TSH (100 mu/ml) or TPA (100 nM) for 40 min at 
37°C prior to assessment of protein kinase C. The 
measurement of protein kinase C activation in 
human neutrophils has been previously reported 
by the present authors [12]. All assays were per- 
formed in duplicate. 
2.2.6. Statistical analyses 
All statistical analyses were performed using a 
one-way analysis of variance on the Epistat com- 
puter program. 
3. RESULTS AND DISCUSSION 
The ability of TSH to induce translocation of 
protein kinase C is illustrated in fig.1. At 
10 ml-I/ml TSH cytosolic protein kinase C de- 
creased by 27% and membrane-bound protein 
kinase C increased by 63%. The difference is likely 
due to recruitment of protein kinase C that was 
previously loosely bound to the plasma membrane. 
Persistent translocation of protein kinase C was 
observed at higher TSH concentrations but this 
was noted to be no greater than that seen at 
10 mu/ml. At lower concentrations of TSH, no 
redistribution of protein kinase C was noted (not 
shown). These findings are similar to those of 
Tanabe et al. [13] who studied the effect of TSH 
on protein kinase C in bovine thyroid slices; 
however, in their studies, cytosolic and membrane 
extracts were exposed to different TSH concentra- 
tions. The concentration of TSH required to cause 
protein kinase C translocation is high yet similar to 
Volume 226, number 2 
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Fig.1. Effect of TSH on the translocation of protein 
kinase C in porcine thyroid cell extracts. Each point 
represents the mean of 7 separate experiments. All 
values are statistically significant compared to controls 
with a minimum p value of <0.02 except where noted. 
that noted to produce IP3 generation in human 
thyroid slices [8]. Although it is conceivable that 
our TSH preparation could contain a protein 
kinase C activator other than TSH, IP3 generation 
in human thyroid slices was produced by the same 
Table 1 
Time course of TSH-stimulated protein kinase C 
translocation in porcine thyroid cell extracts 
Time (min) PKC activity (pmol 32P/min 
per mg protein) 
Cytosol Membrane 
TSH (100 mu/ml) 
0 771 f 48 427 + 46 
1 765 + 45 441 + 34 
5 744 * 13 384 + 18 
15 745 2 44 491 + 88 
40 679 + 16b 628 z!z 70a 
TPA (lo-’ M) 
40 631 * 8” 640 + 59” 
a p < 0.001 vs control 
b p < 0.002 vs control 
TPA was included as a positive control. Data shown are 
representative of 2 closely agreeing experiments 
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Table 2 
Effects of TSH on the translocation of protein kinase C 
in human neutrophils 
PKC activity (pmol 32P/min 
per mg protein) 
Cytosol (Vo) Membrane (olo) 
Control 359 - 56.5 - 
TSH (100 mu/ml) 187 (58.8) 64.6 (114) 
TPA (100 nM) 211 (52.1) 69.0 (122) 
Data shown are representative of 2 closely agreeing 
experiments 
type of TSH preparation as used in this study with 
similar results when purified bovine or human 
TSH was used [8]. 
Time-course studies revealed in table 1 showed 
that the redistribution of protein kinase C occurred 
only after 40 min. A similar prolonged time course 
was observed for IP3 generation by TSH [8]. To 
determine whether the effect of TSH was organ- 
specific, the ability of TSH to cause translocation 
of PKC in human neutrophils was assessed and the 
results are shown in table 2. Surprisingly, TSH 
produced changes in the redistribution of protein 
kinase C similar to those induced by TPA. 
Previous reports have demonstrated TSH recep- 
tors in human neutrophils [14] and further studies 
to determine whether TSH can activate PKC in 
other non-thyroidal tissues containing TSH recep- 
tors are in progress. 
To determine whether TSH and phorbol esters 
activate protein kinase C via a similar mechanism, 
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Fig.2. Effect of TSH pre-exposure,on protein kinase C 
translocation induced by TPA in porcine thyroid cell 
extracts. The results shown have been pooled from 5 
separate experiments. No effect was seen if TSH was 
added after TPA (not shown). 
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porcine thyroid cells were pre-incubated with TSH 
(100 mu/ml, 37”C, 40 min), resuspended and ex- 
posed to TPA (100 nM, 37”C, 40 min) prior to 
protein kinase C assay. The results are shown in 
fig.2. In control cells pre-treated with buffer, TPA 
caused a significant 0, < 0.001) translocation of 
protein kinase C (open bars) as previously de- 
scribed [6]. However, in cells pre-treated with 
TSH, modulation of the phorbol-mediated trans- 
location of protein kinase C was noted. In the 
cytosolic component, less protein kinase C was 
mobilized (hatched bar, p < 0.02) compared to 
cells treated with TPA only. A corresponding 
change was evident in the membrane component 
which just failed to reach statistical significance. 
These findings suggest hat TSH and TPA act on 
similar pools of cellular protein kinase C. It is in- 
teresting to note that concanavalin A which can 
bind TSH prevents the phorbol-mediated redistri- 
bution of protein kinase C in rat glioma C6 cells 
1151. 
The mechanism by which thyroidal protein 
kinase C is activated is the subject of ongoing in- 
vestigation. Although previous studies have shown 
that TSH promotes 32P incorporation into 
phosphatidylinositol [ 16,171, TSH stimulation of 
inositol phosphate generation has not been 
demonstrated in dog [18], calf [19] or ovine 
thyroid [20] but has been recently observed in 
human thyroid [8]. In porcine thyroid tissue, TSH 
transiently stimulated diacylglycerol formation 
with concomitant changes in PI [21]. Whether pro- 
tein kinase C is activated in porcine thyroid cells 
via this mechanism remains to be elucidated. 
In summary, our studies have demonstrated that 
TSH causes the translocation of protein kinase C 
in porcine thyroid cell extracts. These results pro- 
vide direct evidence for the existence of a TSH- 
dependent signal transduction system involving 
protein kinase C activation in porcine thyroid. The 
role of this process in the regulation of thyroid 
function and growth remains to be explored. 
ACKNOWLEDGEMENTS 
This work was supported by a grant (MA-9826) 
from the Medical Research Council of Canada and 
the Alberta Heritage Foundation for Medical 
Research. The authors wish to thank Mrs V. 
Frazer for excellent secretarial assistance, Mrs L. 
226 
Kwan-Yeung for technical support and Gainer’s, 
Inc., for supplying thyroid glands. 
REFERENCES 
HI 
VI 
131 
[41 
PI 
161 
171 
PI 
191 
1101 
Ull 
WI 
1131 
1141 
WI 
1161 
v71 
1181 
iI91 
WI 
WI 
Nishizuka, Y. (1986) Science 233, 305-312. 
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., 
Kikkawa, U. and Nishizuka, Y. (1982) J. Biol. 
Chem. 257, 7847-7851. 
Bachrach, L.K., Eggo, M.C., Mak, W.W. and 
Burrow, G.N. (1985) Endocrinology 116, 
1603-1609. 
Roger, P.P., Reuse, S., Servais, P., Van 
Heuverswyn, B. and Dumont, J.E. (1986) Cancer 
Res. 46, 898-906. 
Haye, B., Aublin, J.L., Champion, S., Lambert, 
B. and Jacquemin, C. (1985) Biochem. Pharmacol. 
34, 3795-3802. 
Ginsberg, J. and Murray, P.G. (1986) FEBS Lett. 
206, 209-312. 
Baxter, J.D. and Funder, J.W. (1979) N. Engl. J. 
Med. 301, 1149-1161. 
Laurent, E., Mockel, J., Van Sande, J., Graff, I. 
and Dumont, J.E. (1987) Mol. Cell. Endocrinol. 
52, 273-278. 
Ginsberg, J., Shewring, G. and Rees Smith, B. 
(1983) Clin. Endocrinol. 19, 305-3 11. 
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and 
Randall, R.J. (1951) J. Biol. Chem. 193, 265-275. 
Kraft, A.S. and Anderson, W.B. (1983) Nature 30, 
621-623. 
Parente, J.E., Davis, P. and Wong, K. (1987) 
Inflammation 11, 381-388. 
Tanabe, A., Nielsen, T.B., Sheela Rani, C.S. and 
Field, J.B. (1985) Arch. Biochem. Biophys. 243, 
92-99. 
Chabaud, 0. and Lissitzky, S. (1977) Mol. Cell. 
Endocrinol. 7, 79-87. 
Patel, J. and Kassis, S. (1987) Biochem. Biophys. 
Res. Commun. 144, 1265-1272. 
Scott, T.W., Jay, SM. and Freinkel, N. (1966) 
Endocrinology 79, 591-600. 
Gerard, C., Haye, B., Jacquemin, C. and 
Mauchamp, J. (1982) Biochim. Biophys. Acta 710, 
359-369. 
Graff, I., Mockel, J., Laurent, E., Erneux, C. and 
Dumont, J.D. (1987) FEBS Lett. 210, 204-210. 
Lippes, H.A. and Spaulding, S.W. (1986) 
Abstracts of the 61st Annual Meeting of the 
American Thyroid Association, A91. 
Eggo, M.C., Bachrach, L.K., Pratt, M.A.C., 
Lippes, H., Becks, G. and Burrow, G.N. (1987) 
Abstracts of the 62nd Annual Meeting of the 
American Thyroid Association, A66. 
Igarashi, Y. and Kondo, Y. (1980) Biochem. Bio- 
phys. Res. Commun. 97, 759-765. 
